UNION CITY, Calif.--(BUSINESS WIRE)--Celltheon today announced the commercial launch of its CHO-K1 based OmniCHO™ Transient Expression Kit, a breakthrough technology poised to transform preclinical ...
ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHO TM Transient Expression System. Due to its enhanced plasmid ...
In the pursuit of faster and more reliable recombinant protein production, transient transfection has emerged as a cornerstone of early biopharmaceutical development. Compared to stable transfection, ...
Transient expression yields can be greatly enhanced by optimizing the transfection system and removing undesirable signals from the gene. Because manipulations such as codon optimization and removal ...